SRTS Sensus Healthcare
Sensus Healthcare earnings company data as of 12:01 PM ET 10/23
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 13 Aug | EPS | — | -0.53 | — |
| Rev | — | $2.3M | — |
Insider trades
Open-market buys and sales by SRTS's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $728K bought by 3 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Eric Sachetta DirectorBuy$226K 64,841 shares at $3.48 +28% to stakeTraded Aug 28–31 Filed Aug 31
-
Eric Sachetta DirectorBuy$67K 20,633 shares at $3.23 +9.9% to stakeTraded Aug 26–27 Filed Aug 28
-
Eric Sachetta DirectorBuy$113K 34,697 shares at $3.25 +20% to stakeTraded Aug 24 Filed Aug 25
-
Eric Sachetta DirectorBuy$98K 31,000 shares at $3.16 +22% to stakeTraded Aug 20–21 Filed Aug 24
-
Joseph C Sardano CEOBuy$60K 20,000 shares at $3.02 +1.7% to stakeTraded Aug 20 Filed Aug 24
-
Eric Sachetta DirectorBuy$5,003 1,500 shares at $3.34 +1.1% to stakeTraded May 12 Filed May 12
-
Eric Sachetta DirectorBuy$7,620 2,000 shares at $3.81 +1.4% to stakeTraded Feb 24 Filed Feb 26
-
Eric Sachetta DirectorBuy$28K 7,000 shares at $3.93 +5.3% to stakeTraded Nov 21, 2025 Filed Nov 21, 2025
-
Eric Sachetta DirectorBuy$11K 2,500 shares at $4.50 +1.9% to stakeTraded Nov 13, 2025 Filed Nov 20, 2025
-
Michael Sardano President and General CounselBuy$3,800 1,000 shares at $3.80 +0.8% to stakeTraded Nov 18, 2025 Filed Nov 19, 2025
-
Joseph C Sardano CEOBuy$101K 25,000 shares at $4.03 +2.1% to stakeTraded Nov 18, 2025 Filed Nov 19, 2025
-
Michael Sardano President and General CounselBuy$8,546 2,000 shares at $4.27Traded Nov 11, 2025 Filed Nov 18, 2025
Also filed in the last 12 months, not counted as buying or selling: 1 stock grant.
SEC filings
Recent issuer filings from EDGAR, 20 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| 10-K | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 4.01,9.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.